Education-based Physical Therapy Approach for Adhesive Capsulitis

NCT03245476 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2017-08-10

No results posted yet for this study

Summary

This study aims, by means of a randomized control trial, to investigate which treatment method (corticoid injection + physiotherapy with a focus on manual therapy and home-exercises versus corticosteroid injection + physiotherapy with focus on education and supported home exercises) gives better results on clinically relevant outcomes (range of glenohumeral motion, psychological factors, pain, shoulder function, quality of life) and on parameters derived from arthroscopic glenohumeral investigation by means of MRI.

Furthermore, associations between (1) the results on the MRI investigation, (2) the range of glenohumeral motion, (3) shoulder function and pain, and (4) psychological factors will be assessed at different time-points (before and at 6-12-18 and 52 weeks after the first injection).

Conditions

  • Adhesive Capsulitis

Interventions

OTHER

Physical therapy focus on manual therapy and home-exercises

corticoid injection + physiotherapy with a focus on manual therapy and home-exercises

OTHER

Physical therapy focus on education and supported home exercises

corticosteroid injection + physiotherapy with focus on education and supported home exercises

Sponsors & Collaborators

  • Jessa Hospital

    collaborator OTHER
  • Hasselt University

    lead OTHER

Principal Investigators

  • Liesbet De Baets, dr. · Hasselt University

  • Annick Timmermans, prof. dr. · Hasselt University

  • Carl Dierickx, prof. dr. · Jessa ziekenhuis, Universiteit Hasselt

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-09-04
Primary Completion
2019-09-04
Completion
2019-09-04

Countries

  • Belgium

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03245476 on ClinicalTrials.gov